NASDAQ · Financial Statements

Vivos Therapeutics, Inc. (VVOS) Financial Statements

$0.15 NASDAQ: VVOS Market Cap $2.04M

Vivos Therapeutics, Inc. most recently reported annual revenue of $17.0M, net profit of $-21.0M, revenue has compounded at 5.5% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$17.0M$16.0M$14.0M$15.0M$17.0M
Operating Profit$-19.0M$-25.0M$-17.0M$-11.0M$-20.0M
Net Profit$-20.0M$-24.0M$-14.0M$-11.0M$-21.0M
EPS$-23.89$-25.90$-11.14$-2.22$-2.06
Op Margin-115.3%-156.2%-125.3%-74.3%-114.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$34.0M$14.0M$11.0M$15.0M$25.0M
Total Liabilities$8.0M$9.0M$10.0M$7.0M$27.0M
Cash$24.0M$4.0M$2.0M$6.0M$2.0M
Borrowings$2.0M$2.0M$2.0M$2.0M$14.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-16.0M$-20.0M$-12.0M$-13.0M$-15.0M
Investing Cash Flow$-5.0M$-2.0M$-2.0M$-1.0M$-10.0M
Financing Cash Flow$-1.0M$0$0$10.0M$0
Net Cash Flow$6.0M$-21.0M$-2.0M$5.0M$-4.0M
Free Cash Flow$-18.0M$-21.0M$-13.0M$-13.0M$-18.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.54
FCF Yield-854.26%
Quick Ratio0.21
Interest Coverage-20.51
Return 1Y-93.87%
Return 3Y-94.79%
Return 5Y-99.59%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
VVOS Overview VVOS Dividend Run Stock Screener